PMID- 30524707 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20191120 IS - 2048-6790 (Print) IS - 2048-6790 (Electronic) IS - 2048-6790 (Linking) VI - 7 DP - 2018 TI - Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: a double-blind cross-over trial. PG - e33 LID - 10.1017/jns.2018.23 [doi] LID - e33 AB - The increased prevalence of lifestyle diseases, such as the metabolic syndrome and type 2 diabetes mellitus (T2DM), calls for more knowledge on dietary treatments targeting the specific metabolic pathways involved in these conditions. Several studies have shown a protein preload before a meal to be effective in lowering the postprandial glycaemic response in healthy individuals and patients with T2DM. The aim of the present study was to assess the effect of a marine protein hydrolysate (MPH) from Atlantic cod (Gadus morhua) on postprandial glucose metabolism in healthy, middle-aged to elderly subjects. This double-blind cross-over trial (n 41) included two study days with 4-7 d wash-out in between. The intervention consisted of 20 mg of MPH (or casein as control) per kg body weight given before a breakfast meal. The primary outcome was postprandial response in glucose metabolism, measured by samples of serum glucose, insulin and plasma glucagon-like peptide 1 (GLP-1) in 20 min intervals for 180 min. In a mixed-model regression analysis, no differences were observed between MPH and control for postprandial glucose concentration (mean difference: -0.04 (95 % CI -0.17, 0.09) mmol/l; P = 0.573) or GLP-1 concentration (mean difference between geometric means: 1.02 (95 % CI 0.99, 1.06) pmol/l; P = 0.250). The postprandial insulin concentration was significantly lower after MPH compared with control (mean difference between geometric means: 1.067 (95 % CI 1.01, 1.13) mIU/l; P = 0.032). Our findings demonstrate that a single dose of MPH before a breakfast meal reduces postprandial insulin secretion, without affecting blood glucose response or GLP-1 levels, in healthy individuals. Further studies with repeated dosing and in target groups with abnormal glucose control are warranted. FAU - Dale, Hanna Fjeldheim AU - Dale HF AUID- ORCID: 0000-0002-0710-6057 AD - Department of Clinical Medicine, Centre for Nutrition, University of Bergen, Bergen, Norway. AD - Division of Gastroenterology, Department of Medicine, Haukeland University Hospital, Bergen, Norway. FAU - Jensen, Caroline AU - Jensen C AD - Department of Clinical Medicine, Centre for Nutrition, University of Bergen, Bergen, Norway. FAU - Hausken, Trygve AU - Hausken T AD - Department of Clinical Medicine, Centre for Nutrition, University of Bergen, Bergen, Norway. AD - Division of Gastroenterology, Department of Medicine, Haukeland University Hospital, Bergen, Norway. AD - National Centre of Functional Gastrointestinal Disorders, Haukeland University Hospital, Bergen, Norway. FAU - Lied, Einar AU - Lied E AD - Firmenich Bjorge Biomarin AS, Ellingsoy, Alesund, Norway. FAU - Hatlebakk, Jan Gunnar AU - Hatlebakk JG AD - Department of Clinical Medicine, Centre for Nutrition, University of Bergen, Bergen, Norway. AD - Division of Gastroenterology, Department of Medicine, Haukeland University Hospital, Bergen, Norway. AD - National Centre of Functional Gastrointestinal Disorders, Haukeland University Hospital, Bergen, Norway. FAU - Bronstad, Ingeborg AU - Bronstad I AD - Department of Clinical Medicine, University of Bergen, Bergen, Norway. AD - National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, Norway. FAU - Lihaug Hoff, Dag Arne AU - Lihaug Hoff DA AD - Division of Gastroenterology, Department of Medicine, Alesund Hospital, More & Romsdal Hospital Trust, Alesund, Norway. AD - Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway. FAU - Lied, Gulen Arslan AU - Lied GA AD - Department of Clinical Medicine, Centre for Nutrition, University of Bergen, Bergen, Norway. AD - Division of Gastroenterology, Department of Medicine, Haukeland University Hospital, Bergen, Norway. AD - National Centre of Functional Gastrointestinal Disorders, Haukeland University Hospital, Bergen, Norway. LA - eng PT - Journal Article DEP - 20181128 PL - England TA - J Nutr Sci JT - Journal of nutritional science JID - 101590587 EIN - J Nutr Sci. 2019 Jan 18;8:e1. PMID: 30719283 PMC - PMC6277920 OTO - NOTNLM OT - BCAA, branched-chain amino acids OT - Fish protein OT - GLP-1, glucagon-like peptide 1 OT - Glucose metabolism OT - MPH, marine protein hydrolysate OT - Marine peptides OT - Marine protein hydrolysate OT - T2DM, type 2 diabetes mellitus EDAT- 2018/12/14 06:00 MHDA- 2018/12/14 06:01 PMCR- 2018/01/01 CRDT- 2018/12/08 06:00 PHST- 2018/10/29 00:00 [received] PHST- 2018/11/01 00:00 [accepted] PHST- 2018/12/08 06:00 [entrez] PHST- 2018/12/14 06:00 [pubmed] PHST- 2018/12/14 06:01 [medline] PHST- 2018/01/01 00:00 [pmc-release] AID - 00023 [pii] AID - 10.1017/jns.2018.23 [doi] PST - epublish SO - J Nutr Sci. 2018 Nov 28;7:e33. doi: 10.1017/jns.2018.23. eCollection 2018.